People · Operator

Dennis Barry Huang

Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology

1
Companies
2
Filings
$36.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bonti, Inc.BiotechnologySeries B$36.0M$613.7M2015
Operator network

Dennis Barry Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Wajdie Ahmad · 3 companies · 1 sharedWajdie AhmadDavid Ramsay · 2 companies · 1 sharedDavid RamsayDENNIS HUANG · 2 companies · 1 sharedDENNIS HUANGFauad Hasan · 2 companies · 1 sharedFauad HasanJonathan Lim, M.D. · 2 companies · 1 sharedJonathan Lim, M.D.ALEXEY KONOV, Ph.D. · 1 companies · 1 sharedALEXEY KONOV, Ph.…David Barry Ramsay · 1 companies · 1 sharedDavid Barry RamsayFauad Barry Hasan · 1 companies · 1 sharedFauad Barry HasanKenton Barry Abel · 1 companies · 1 sharedKenton Barry AbelLeonard Barry Brandt · 1 companies · 1 sharedLeonard Barry Bra…Michael Barry Jarpe · 1 companies · 1 sharedMichael Barry Jar…MICHAEL JARPE · 1 companies · 1 sharedMICHAEL JARPETOM ALBRIGHT · 1 companies · 1 sharedTOM ALBRIGHTWajdie Barry Ahmad · 1 companies · 1 sharedWajdie Barry AhmadBonti, Inc. · $36.0M raisedBonti, Inc.Dennis Barry HuangDH
Dennis Barry Huang Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Dennis Barry Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Wajdie Ahmad13
David Ramsay12
Fauad Hasan12
DENNIS HUANG12
Jonathan Lim, M.D.12
Leonard Barry Brandt11
ALEXEY KONOV, Ph.D.11
TOM ALBRIGHT11
Wajdie Barry Ahmad11
MICHAEL JARPE11
David Barry Ramsay11
Michael Barry Jarpe11
Fauad Barry Hasan11
Kenton Barry Abel11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.